About: Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $6.89 (+6.33%)
RGCNASDAQRegencell Bioscience Holdings Ltd
Loading watchlist status…
Regencell Bioscience Holdings Ltd share price
RGC price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
RGC price performance
25.05%
5D
13.88%
1M
-67.19%
YTD
-46.34%
1Y
RGC price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NASDAQ rank
N/ASector Rank
N/ARGC Market Signals